Among them, the PI3K/AKT signaling pathway is one of the most frequently altered signaling networks in human cancers because of the critical regulation of cell proliferation, survival, growth, and motility, and has become an attractive target in anticancer therapy [20,30,31]. Here, AKT1 is linked to cancer.